References

Bateman SW, Parent JM. Clinical findings, treatment, and outcome of dogs with status epilepticus or cluster seizures: 156 cases (1990–1995). J Am Vet Med Assoc. 1999; 215:(10)1463-1468

Berendt M, Farquhar RG, Mandigers PJJ International veterinary epilepsy task force consensus report on epilepsy definition, classification and terminology in companion animals. BMC Vet Res. 2015; 11:(1) https://doi.org/10.1186/s12917-015-0461-2

Cagnotti G, Odore R, Bertone I Open-label clinical trial of rectally administered levetiracetam as supplemental treatment in dogs with cluster seizures. J Vet Intern Med. 2019; 33:(4)1714-1718 https://doi.org/10.1111/jvim.15541

Charalambous M, Bhatti SFM, Van Ham L Intranasal midazolam versus rectal diazepam for the management of canine status epilepticus: a multicenter randomized parallel-group clinical trial. J Vet Intern Med. 2017; 31:(4)1149-1158 https://doi.org/10.1111/jvim.14734

Cornelis I, Van Ham L, Gielen I Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: a review. Vet J. 2019; 244:37-44 https://doi.org/10.1016/j.tvjl.2018.12.007

Gindiciosi B, Palus V, Eminaga E Serum bromide concentrations following loading dose in epileptic dogs. J Small Anim Pract. 2014; 55:(2)108-111 https://doi.org/10.1111/jsap.12173

Hong KS, Cho YJ, Lee SK Diffusion changes suggesting prominent vasogenic oedema during partial status epilepticus. Seizure. 2004; 13:(5)317-321 https://doi.org/10.1016/j.seizure.2003.08.004

Musulin SE, Mariani CL, Papich MG. Diazepam pharmacokinetics after nasal drop and atomized nasal administration in dogs. J Vet Pharmacol Ther. 2011; 34:(1)17-24 https://doi.org/10.1111/j.1365-2885.2010.01186.x

Platt SR, Haag M. Canine status epilepticus: a retrospective study of 50 cases. J Small Anim Practice. 2002; 43:(4)151-153 https://doi.org/10.1111/j.1748-5827.2002.tb00047.x

Podell M, Fenner WR, Powers JD. Seizure classification in dogs from a non-referral based population. J Am Vet Med Assoc. 1995; 206:(11)1721-1728

Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011; 134:(10)2802-2818 https://doi.org/10.1093/brain/awr215

Steffen F, Grasmueck S. Propofol for treatment of refractory seizures in dogs and a cat with intracranial disorders. J Small Anim Practice. 2000; 41:(11)496-499 https://doi.org/10.1111/j.1748-5827.2000.tb03971.x

Tesoro EP, Brophy GM. Pharmacological management of seizures and status epilepticus in critically ill patients. J Pharm Pract. 2010; 23:(5)441-454 https://doi.org/10.1177/0897190010372321

Managing canine status epilepticus in practice

02 September 2020
8 mins read
Volume 25 · Issue 8

Abstract

Status epilepticus is a common emergency encountered in general practice, and one that can be daunting for many to manage. This review summarises the main considerations for patients presenting in status epilepticus, and discusses the treatment options available, specifically with regard to medications that are likely to be available to the general practitioner.

Status epilepticus is a common emergency encountered in general practice, and one that can be daunting for many to manage. Not only must we expect these dogs to arrive at the clinic at unpredictable times, the presentation causes great distress to the accompanying owners, and we may not always have access to the full spectrum of recommended medications to treat it. This article will briefly review the disease as well as the common underlying causes and explore options for treatment available to most general practitioners. Specifically, this article will focus on patients who do not initially respond to first- and second-line interventions.

Status epilepticus is defined as seizure activity that lasts for longer than 5 minutes, or the occurrence of two or more seizures without complete recovery of consciousness in between. Two or more seizure episodes that occur within a 24-hour period with complete recovery of consciousness in between are termed cluster seizures (Berendt et al, 2015). Status epilepticus represents a life-threatening emergency that requires emergency intervention. Prolonged seizure activity is associated with cerebral damage, characterised by neuronal cell necrosis and gliosis (Shorvon and Ferlisi, 2011) as well as cerebral oedema secondary to blood–brain barrier disruption (Hong et al, 2004). These may contribute to longer durations of status epilepticus and becoming less responsive to anticonvulsant medication (Podell et al, 1995). Systemic effects of status epilepticus are mainly mediated by systemic release of catecholamines, commonly leading to hypertension, tachycardia, hyperglycaemia, hyperthermia, and subsequently can cause cardiac arrhythmias, acidosis, rhabdomyolysis, hypotension, shock, noncardiogenic pulmonary oedema, and acute tubular necrosis. If the seizure continues for over 30 minutes, the risk of hypoglycaemia, hyperthermia, hypoxia, respiratory failure, acidosis, hyperkalaemia, hyponatraemia, and uraemia increases (Tesoro and Brophy, 2010).

Register now to continue reading

Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.